Search for Clinical Trial Results
Contracture - 60 Studies Found
Status | Study |
Completed |
Study Name: A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's Contracture Condition: Dupuytren's Contracture Date: 2007-09-11 Interventions: Biological: collagenase clostridium histolyticum Single dose of AA4500 0.58 mg into the cord |
Completed |
Study Name: Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture Condition: Dupuytrens Contracture Date: 2012-02-18 Interventions:
|
Completed |
Study Name: Botulinum Toxin A to Treat Flexion Contracture After Total Knee Arthroplasty Condition: Flexion Contracture Following Total Knee Replacement Date: 2013-04-08 Interventions:
|
Completed |
Study Name: Injectable Collagenase For Burns' Associated Contracture Condition: Burn's Associated Contracture Date: 2010-11-03 Interventions: Drug: Xiaflex (FDA approved collagenase) 0.58mg of collagenase will be diluted in saline and injected in |
Withdrawn |
Study Name: Joint Stiffness Following Knee Replacement Surgery Condition: Joint Contracture Date: 2008-04-21 |
Not yet recruiting |
Study Name: BOND Study: the Benefit Of Night Splinting in Dupuytrens' Condition: Dupuytren Contracture Date: 2017-01-23 Interventions: Device: Thermoplastic Hand Splint Thermoplastic Night splint created and moulded to the individual patie |
Active, not recruiting |
Study Name: Investigations of Mechanisms and Treatment in Post-traumatic Joint Contractures Condition: Joint Contractures Date: 2013-07-10 Interventions:
|
Completed |
Study Name: Post Approval Commitment Study Condition: Dupuytren's Contracture Date: 2011-09-08 Interventions:
|
Not yet recruiting |
Study Name: Comparison of Outcome of Post Burn Flexion Contracture Release Under Tourniquet Verses Tumescent Technique in Children Condition:
Date: 2015-07-12 Interventions:
|
Completed |
Study Name: Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex) Condition: Dupuytren's Contracture Date: 2010-10-26 Interventions: Drug: Xiapex Xiapex 0.58 mg in diluent, 0.25 ml for MP joints and 0.20 ml for PIP joints, injection to c |